If you're working with research-grade peptides, treat reconstitution as a precision protocol, not a rough guideline
TABLE 3 Pharmacokinetic parameters of BPC157 in rats following repeat intramuscular administration of 100 g/kg BPC157 for seven consecutive days (mean SD, n = 6)
For a comprehensive overview of how peptides compare across tissue systems, our joint and tendon peptide research guide provides useful context
Second-line treatments, known as device-aided therapies (DATs), have been developed for LDRCs, such as continuous subcutaneous apomorphine infusion (CSAI), continuous subcutaneous foslevodopafoscarbidopa, infusion of levodopacarbidopa intestinal gel (LCIG entacapone) and subthalamic deep brain stimulation
Stability: Chemically stable at room temperature when protected from direct light and moisture